By www.reliableresearchtimes.com
Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status And Forecast 2023-2027 Story
105
$ 3900
Nonalcoholic Steatohepatitis (NASH) Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead